Woodline Partners’s Fractyl Health GUTS Stock Holding History
Bought
Maintained
Sold
Other funds holding GUTS
NCM
CCM
PFCS
GCGM
DMC
MC
MCM
Woodline Partners's GUTS Position: Q2 2026 in Review
Woodline Partners reduced its Fractyl Health (GUTS) stake by 20% in Q2 2026, selling an estimated $326K and leaving 1,783,592 shares worth $1.42M. The position accounts for ﹤0.01% of the portfolio, ranked #875.
Woodline Partners first reported a position in GUTS in Q1 2024 and has held it in 10 quarters since. The position peaked at $12.1M in Q4 2025. 77 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.
- Woodline Partners held 1,783,592 shares of Fractyl Health worth $1.42M as of Q2 2026.
- Woodline Partners sold 458,087 Fractyl Health shares in Q2 2026, an estimated $326K.
- Fractyl Health made up ﹤0.01% of Woodline Partners's portfolio in Q2 2026, its #875 holding.
- Woodline Partners first reported a position in Fractyl Health in Q1 2024 and has held it in 10 quarters since.
- Woodline Partners's Fractyl Health position peaked at $12.1M in Q4 2025.
- 77 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.
Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.